Daclizumab Injection

Get a Price/Quote

MOQ : 10 Vials

Daclizumab Injection Specification

Origin of Medicine
India

Brand Name
Daclizumab Injection

Pacakaging (Quantity Per Box)
VIAL

Indication
Transplant rejection prevention

Packaging Type
Glass Bottle

Dosage Form
Suspension

Life Span
24 months

Salt Composition
Daclizumab

Drug Type
Allopathic

Physical Form
Injectable

Function
Immunosuppressant

Recommended For
Clinical

Dosage
1ml-5ml

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
Single dose vial

Storage Instructions
Store below 25C

Is It Portable
Portable

Daclizumab Injection Trade Information

Minimum Order Quantity
10 Vials

Payment Terms
Cash Advance (CA)

Supply Ability
5000 Vials Per Month

Delivery Time
5-7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

About Daclizumab Injection

Grab the extraordinary power of Daclizumab Injection, a crackerjack immunosuppressant engineered for potent clinical application. Explore its majestic efficacy in preventing transplant rejection in adults, uniquely formulated in a 1ml-5ml suspension dosage. Each portable glass vial delivers the robust benefits of allopathic innovation with precise dosing for individualized patient needs. With India as its origin, this product undergoes rigorous standards and is available as a single-dose vial to ensure optimal patient safety and convenience. Store below 25C to preserve its exceptional lifespan of 24 months.

Daclizumab Injection: Competitive Edge & Applications

Daclizumab Injection offers a distinctive advantage with its majestic role in transplant rejection prevention. It boasts an extraordinary track record in immunosuppressive therapy, suitable for clinical settings under professional supervision. Crackerjack in consistency, this suspension form ensures precise dosage and reliability. Its portable glass vial packaging guarantees both patient and clinician convenience, lending itself to a wide variety of clinical applications while complying with international pharmaceutical standards.

Packaging, Delivery, and Domestic Market Coverage

Each Daclizumab Injection is delivered in a secure glass bottle, expertly packaged as a single-use vial to maintain utmost integrity. Transportation is streamlined for safe handling from India to various destinations, with competitive quotations available upon request. The product is primarily supplied within the main domestic market, catering to hospitals and clinics nationwide, with FOB port arrangements supporting efficient logistics and timely delivery for all orders.

FAQ's of Daclizumab Injection:

Q: How is Daclizumab Injection administered?

A: Daclizumab Injection is administered as an injectable suspension, usually by a healthcare professional, following dosage guidelines specified by a physician.

Q: What is the primary indication for using Daclizumab Injection?

A: Daclizumab Injection is primarily used to prevent transplant rejection in adult patients, functioning as a powerful immunosuppressant.

Q: When should Daclizumab Injection be stored and at what temperature?

A: The injection should be stored below 25C and is best kept in a clinical refrigeration environment to preserve its 24-month shelf life.

Q: Where is Daclizumab Injection sourced and who is it suitable for?

A: This product originates from India and is suitable for adult patients, primarily in clinical settings as directed by a healthcare provider.

Q: What are the packaging and transportation details for Daclizumab Injection?

A: Each dose is packed in a glass bottle and single-dose vial, with transportation coordinated from India via the agreed FOB port to ensure safe and timely delivery.

Tell us about your requirement